Its long history of safe use in traditional medicine makes it a valuable natural alternative to support healthy metabolism without the side effects associated with pharmaceutical GLP-1 agonists
Recently, a phase II multicentre, double-blind, randomized controlled trial including 338 adults with obesity were administered retatrutide (1, 2 mg starting dose increased to 4, 2 mg starting dose increased to 8, 2 mg starting dose increased to 12 mg) compared to placebo over 48 weeks [64]
Future obesity treatment may segment patients by metabolic phenotype, comorbidities, weight-loss targets, liver fat burden, cardiovascular risk, and treatment tolerance
Step 2: Evaluation We will evaluate your BMI and cardiometabolic risk factors to determine if GLP-1 or another medical weight loss injection is suitable for you
GLP-1s are tools, not solutions
If your insurance plan doesnt cover semaglutide, you can ask your healthcare provider to help you submit a request for a medical exception
